Biotech

All Articles

Turnstone lays off 60%, shocks C-suite to extend cash

.Turnstone Biologics is actually lowering its own head count through 60% and also shocking its C-sui...

Gilead quits on $15M MASH wager after weighing preclinical information

.In a year that has seen an approval and a boating of readouts for metabolic dysfunction-associated ...

Texas biotech axes cancer cells pact, pins really hopes on weight problems

.Alaunos Therapeutics is axing an arrangement with Precigen, giving up licensing civil rights to a c...

Capricor shares even more records for DMD therapy after starting BLA

.Capricor Rehabs is actually taking a triumph tour for their stage 2 Duchenne muscle dystrophy (DMD)...

FDA areas Kezar lupus trial in hold adhering to 4 individual fatalities

.The FDA has actually placed Kezar Lifestyle Sciences' lupus trial on grip after the biotech hailed ...

Phase 3 Academic Stone trial reaches SMA goal, sending stock up 200%

.A phase 3 test of Intellectual Rock's back muscle atrophy (SMA) candidate has struck its own key en...

CAMP 4 is most current to eye IPO, while Upstream point out $182M strategy

.RNA biotech CAMP4 Therapies has actually defined think about a $67 thousand IPO, with inflammation-...

Galecto purchases leukemia medication, drops bone cancer cells property in pivot

.A year after the breakdown of an idiopathic pulmonary fibrosis prospect sent out Galecto on a hunt ...

Judo throws down $100M to knock out renal illness

.Taking the mat is actually Judo Biography, a promising biotech equipped along with $100 million to ...

AstraZeneca pays out CSPC $100M for preclinical cardiovascular disease medication

.AstraZeneca has paid CSPC Drug Team $one hundred thousand for a preclinical heart disease drug. The...